ARTICLE | Clinical News
Conbriza bazedoxifene regulatory update
February 23, 2009 8:00 AM UTC
EMEA's CHMP issued a positive opinion on an MAA from Wyeth for Conbriza bazedoxifene to treat postmenopausal osteoporosis at increased risk of fracture. Wyeth, which is being acquired by Pfizer Inc...